In the face of the surge of primary studies within a certain period of time, the traditional time-consuming systematic review method is difficult to provide evidence-based basis for clinical practice. Rapid review (RR), as an extension of systematic review, can integrate existing research in a limited time to meet the need for rapid decision-making. Currently, RR has been widely used in the field of medical research, but its application status remains unclear.

To explore the current status and hotspot of RR research by using bibliometric analysis.

CNKI and WOS databases were searched for the researches in the field of RR application from 2001 to 2023, a visualization analysis was performed on annual publication volume, countries, institutions, authors, journals, and keywords of Chinese and English literature by the bibliometrics software of VOSviewer and CiteSpace.

A total of 151 articles in Chinese and 1197 in English were included. The publication volume of RR application increased gradually from 2001 to 2023, but the publication volume in foreign was higher than that in China, with more obvious increasing trend. The United Kingdom was the country with the highest publication volume (252), the University of Toronto in Canada was the institution with the highest publication volume (52), and Peking University Third Hospital ranked first in publication volume in China (23). The journal Evaluation and Analysis of Drug-use in Hospitals of China had the highest publication volume in China (22), and the journal BMJ Open had the highest publication volume abroad (42). In China, the author team mainly composed of MEN Peng, ZHAI Suodi and ZHAO Zinan published more research. In foreign, the authors of NUSSBAUMER-STREIT, GARTLEHNER and TRICCO published more studies. The most frequently cited literature in China was mainly about RR application and methodology, rapid assessments of drugs or technologies, and the impact of COVID-19, while the most frequently cited literature in foreign was mainly about the the impact, intervention, and epidemiological factors of COVID-19, or methodological studies of RR. Domestic research hotspots mainly focused on the field of rapid health technology assessment in the safety, efficacy, and cost effectiveness of intervention for chronic or serious diseases. Foreign research hotspots mainly focused on the etiology, intervention, diagnosis, prevention, and impact of COVID-19, and rapid evidence synthesis related to decision-making, such as the safety and effectiveness of the drug intervention in children, health care, cancer treatment or mortality risk in middle-aged and elderly populations.

At present, there is a great difference in the development of RR application in the medical field at home and abroad. The application of RR in foreign is gradually maturing, but in China, it is still in the preliminary stage. The experience of RR application in foreign can be learned to expand the development of domestic RR application.

面对一定时间内原始研究数量的激增，耗时较长的传统系统综述较难及时为临床实践提供循证依据。快速综述（RR）作为系统综述方法的拓展，通过简化步骤和流程，可在有限时间内整合现有研究，从而满足快速决策的需求。目前RR已经被广泛应用到医学研究领域，但其应用现状尚不清楚。

采用文献计量学方法探究RR的研究现状与热点。

基于中国知网和Web of Science核心合集数据库检索2001—2023年有关RR的应用研究，采用文献计量学软件CiteSpace和VOSviewer对中英文文献的年发文量、国家、机构、作者、期刊、关键词等内容进行可视化分析。

共纳入中文文献151篇，英文文献1 197篇。2001—2023年RR应用研究发文量逐步上升，但国外较国内发文量多且增加趋势明显；英国是发文量最多的国家（252篇），加拿大多伦多大学是发文量最多的机构（52篇），北京大学第三医院发文量居国内首位（23篇）；国内发文量最多的期刊是《中国医院用药评价与分析》（22篇），国外发文量最多的期刊是BMJ Open（42篇）；国内以门鹏、翟所迪、赵紫楠等为主的作者团队发表研究较多；国外以NUSSBAUMER-STREIT、GARTLEHNER、TRICCO等为主的作者团队发表研究较多；国内引用频次较多的文献以RR应用和方法学介绍、药物或技术的快速评估、新型冠状病毒感染（COVID-19）的影响等内容为主，国外引用频次较多的文献以COVID-19影响、治疗和流行病学因素的快速评估，或快速综述方法学研究等内容为主；国内研究热点主要集中在慢性或重大疾病干预安全性、有效性、经济性的快速卫生技术评估领域，国外研究热点主要集中在COVID-19病因、干预、诊断、预防及影响，儿童药物干预安全性及有效性、中老年人群医疗卫生保健、癌症治疗或死亡风险等与决策制定相关的快速证据综合领域。

目前国内外医学领域RR应用研究发展差异较大，国外RR应用研究趋向成熟，国内尚处于初步发展阶段。未来可借鉴国外应用经验，不断拓宽国内RR发展领域。